National Advisory Council Agenda

135th Meeting of the National Advisory Council on Drug Abuse

Virtual Meeting – May 12, 2020

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

11:00 a.m. Call to Order
Nora Volkow, M.D.
Director, NIDA


Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
11:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Kurt Rasmussen, Ph.D., Director

12:15 a.m. Break

Videocast:

Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Dr. Gillian Acca, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.

https://videocast.nih.gov/watch=36351

Open Session

12:45 p.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
1:00 p.m. Director's Report
Nora Volkow, M.D. Director, NIDA
11:50 p.m. Discussion
Council Members
2:15 p.m. Communicating NIDA Science and Strategic Planning Update
Jack Stein, Ph.D.
NIDA Chief of Staff, 
Director, Office of Science Policy and Communication
2:45 p.m.

DTMC: Strategies, tactics, and accomplishments in facilitating a pipeline of new treatments for Substance Use Disorders
Kurt Rasmussen, Ph.D.
Director, Division of Therapeutics and Medical Consequences

3:15 p.m.

Points to Consider Updates
Susan Weiss, Ph.D.
Director, Division of Extramural Research

3:45 p.m. Concept Clearances​
  • Division of Epidemiology, Services, and Prevention Research (DESPR)
    • Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access – Heather Kimmel, Ph.D., Health Scientist Administrator
    • Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services – Lori Ducharme, Ph.D., Health Scientist Administrator
    • Development & Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation – Richard Jenkins, Ph.D., Health Scientist Administrator
    • AIDS-Science Track Award for Research transition – Richard Jenkins, Ph.D., Health Scientist Administrator
  • Division of Neuroscience and Behavior (DNB)
    • Cutting-Edge Basic Research Awards (CEBRA) – Amy C. Lossie, Ph.D., Health Scientist Administrator
    • Advancing Technologies to Improve Delivery of Pharmacological, Gene Editing, and Cargoes for HIV and SUD Mechanistic or Therapeutic Research – Jonathan Pollock, Ph.D., Branch Chief, Genetics, Epigenetics, and Developmental Neuroscience Branch
    • Elucidating the Effects of ART on Neuronal Function in the Context of SUD – Roger Sorensen, Ph.D., Branch Chief, Integrative Neuroscience Branch
  • Division of Therapeutics and Medical Consequences (DTMC)
    • Device-Based Treatments for Substance Use Disorders – Will M. Aklin, Ph.D., Health Scientist Administrator
  • Office of Research Training, Diversity, and Disparities (ORTDD)
    • Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists – Albert Avila, Ph.D., Deputy Director
    • NIDA Mentored Clinical Scientist Development Program Award – Albert Avila, Ph.D., Deputy Director​
4:15 p.m. Public Comments
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Dr. Gillian Acca, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.
4:30 p.m. Adjourn